Back

Left atrial thrombus in heart failure patients undergoing elective electrical cardioversion despite guideline-recommended anticoagulation: prevalence, predictors and prognosis

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation cardioversion Rhythm Control, Cardioversion EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Luis Lopez Flores

University Hospital of Virgen Macarena, Seville (Spain)

6 More presentations in this session

Presentation thumbnail
Predictors of maintenance of sinus rhythm one year after successful cardioversion of persistent atrial fibrillation and atrial flutter
Assistant Professor N. Radovanovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of electrical cardioversion of atrial fibrillation in the emergency department (HEROMEDICUS study)
Doctor N. Argyriou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of spontaneous conversion to sinus rhythm in patients with symptomatic paroxysmal atrial fibrillation
Doctor P. Cipollone (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Naples score is related to failure to maintain sinus rhythm in long-standing persistent atrial fibrillation patients undergoing electrical cardioversion
Mr K. Gulsen (Turkey, TR)
Presentation thumbnail
Pharmacological cardioversion as a predictor of left atrial scarring in patients undergoing catheter ablation for persistent atrial fibrillation
Mr M. Keseru (Pecs, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation cardioversion

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Prevalence and risk factors of pre-procedural left atrial appendage thrombosis in patients undergoing catheter ablation of atrial fibrillation: a retrospective observational study.
thumbnail
Congress Presentation
Incidence of left atrial thrombi in patients with atrial fibrillation and low thromboembolic risk: do we always need transesophageal echocardiography before rhythm control therapy?
thumbnail
Congress Presentation
Real-world incidence and predictors of LAA thrombus in patients scheduled for an elective atrial tachyarrhythmia ablation.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources